Dataset from A Randomized, Single-Blind, Crossover Study in Healthy Volunteers to Demonstrate the Bioequivalence of Interferon Beta-1a Manufactured by Two Different Processes
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00007190
下载链接
链接失效反馈官方服务：
资源简介：
Biogen Idec has developed a novel process to manufacture Interferon beta-1a (INFB), the
active ingredient of Avonex®, that does not include fetal bovine serum (FBS). This
bioequivalence study is being conducted to confirm the pharmacokinetic (PK) and
pharmacodynamic (PD) comparability of Interferon beta-1a produced by the currently approved
serum-containing process and Interferon beta-1a produced by the new serum-free manufacturing
process.
创建时间：
2024-11-26
